Software, biotech firms and others who develop new ways to do business will be watching closely Monday as the Supreme Court hears a case that could determine if such innovations can be patented.

New York City health officials scrambled to explain themselves Thursday following outraged media reports about bankers who got scarce H1N1 flu vaccines through their employers

DuPont posted an 11 percent jump in third-quarter profit Tuesday, beating Wall Street estimates, but the chemical maker narrowed its earnings outlook for the year.

Clean technology edged out biotechnology to become the largest recipient of venture investment in the United States in the third quarter of 2009, according to new research by the Cleantech Group and Deloitte.

The number-one H1N1 flu concern among U.S. businesses is the availability of a vaccine for employees, according to a new survey by the Business Roundtable.

Drug maker Wyeth, in the process of being acquired by Pfizer, reported a quarterly profit that was better than analysts predicted and also raised its full-year earnings guidance.

Dow Chemical and Algenol Biofuels, a start-up company, are set to announce Monday that they will build a demonstration plant that, if successful, would use algae to turn carbon dioxide into ethanol as a vehicle fuel or an ingredient in plastics.

Global stocks were lower Tuesday, tracking Wall Street's overnight selloff where the U.S. stock market suffered its worst trading day in two months. Experts on CNBC debate how deep the market correction will be.

Middle and high school students across the country are generally falling behind in life sciences, and the nation is at risk of producing a dearth of qualified workers for the fast-growing bioscience industry, according to a report released Monday.